Welcome to Artificially Real, the only life sciences blog dedicated to AI solutions expanding Real World Data research.
Understand the biggest trends in AI impacting the Life Sciences industry. Understand the business values companies are recognizing through the use of LLMs and RWD.
Learn about changes companies have to make to achieve their business goals. Hear about the latest regulatory changes impacting your business operations.
Learn about industry best practices for designing, implementing, operating, and managing AI programs effectively.
Hear about critical regulatory, compliance, and privacy requirements as they change.
Learn how colleagues and peers how tackled similar challenges.
Learn about the innovative AI initiatives being undertaken by fellow Life Sciences firms.
Understand the business goals, processes, changes, and advancements undertaken to realize measurable value from the programs.
See the impacts realized by these inititives.
Read reviews of vendors that offer valuable components needed for effective RWD, AI, and analytics programs.
Learn about the capabilities, functionality, and focus of different vendors. Understand their developments and progress. We continually update our vendor listings to reflect the latest details.
Tags
Interlnking Real World Data At Unprecedented Scale
Tthe fragmented and complex nature of RWD—spread across electronic health records (EHRs), claims data, clinical trials, and patient registries—poses significant challenges to effective analysis. Large Language Models (LLMs) are emerging as transformative tools for linking disparate RWD records, enabling life sciences companies to generate deeper insights and accelerate innovation
Enhancing Real-World Data Analysis: How LLMs Enable Advance Data Linkage
The life sciences industry relies heavily on real-world data (RWD) to drive research, improve clinical outcomes, and support regulatory decision-making. However, the fragmented and complex nature of RWD—spread across electronic health records (EHRs), claims data, clinical trials, and patient registries—poses significant challenges to effective analysis. Large Language Models (LLMs) are emerging as transformative tools for linking disparate RWD records, enabling life sciences companies to generate deeper insights and accelerate innovation.
